Arch Therapeutics, Inc. (ARTH) Files Form 4 Insider Buying : James R Sulat Buys 111,111 Shares

Arch Therapeutics, Inc. (ARTH): James R Sulat , director of Arch Therapeutics, Inc. purchased 111,111 shares on May 26, 2016. The Insider buying transaction was reported by the company on May 31, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.00 per share for a total value of $0.00 , the company said in a SEC Form 4 Filing.

Leave a Reply

Arch Therapeutics, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Arch Therapeutics, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.